| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019995846 |
| P356 | DOI | 10.1038/GT.2016.74 |
| P698 | PubMed publication ID | 27834948 |
| P2093 | author name string | J Li | |
| Y Luo | |||
| X J Liu | |||
| D X Liu | |||
| H W Li | |||
| Y L Zhang | |||
| Q Feng | |||
| J L Yang | |||
| W X Zhao | |||
| X Y Pan | |||
| S J Zhen | |||
| P2860 | cites work | Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting telomerase-positive cancer cells | Q45876565 |
| Computational modeling on the recognition of the HRE motif by HIF-1: molecular docking and molecular dynamics studies | Q46122781 | ||
| Ras p21 overexpression is a late event in prostate-cancer. | Q47759655 | ||
| A comparative immunological analysis of CoCl2 treated cells with in vitro hypoxic exposure. | Q51674736 | ||
| Exposure to aromatic amines and ras and c-erbB-2 overexpression in bladder cancer | Q71791885 | ||
| Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma | Q72611044 | ||
| Differential expression and mutation of the ras family genes in human breast cancer | Q77478461 | ||
| Hepatitis B virus X protein upregulates HSP90alpha expression via activation of c-Myc in human hepatocarcinoma cell line, HepG2 | Q21245106 | ||
| Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells | Q24648994 | ||
| Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo | Q24797399 | ||
| Targeting HIF-1 for cancer therapy | Q27860504 | ||
| Anti-adenovirus activities of shikonin, a component of Chinese herbal medicine in vitro | Q33849742 | ||
| Telomeres and telomerase: implications for cancer and aging | Q33928492 | ||
| Ras in cancer and developmental diseases | Q34202697 | ||
| Blocking oncogenic Ras signaling for cancer therapy | Q34311585 | ||
| KRAS gene mutation in colorectal cancer is correlated with increased proliferation and spontaneous apoptosis | Q34626278 | ||
| The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231. | Q34696613 | ||
| Autophagy induced by HIF1α overexpression supports trophoblast invasion by supplying cellular energy | Q35009585 | ||
| Replicative oncolytic adenoviruses in multimodal cancer regimens | Q35180181 | ||
| Hypoxia inducible factor as a cancer drug target | Q35610688 | ||
| The HIF pathway as a therapeutic target | Q35876589 | ||
| Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation | Q35883071 | ||
| A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues | Q35929342 | ||
| Telomere and telomerase as targets for anti-cancer and regeneration therapies | Q36103191 | ||
| Telomerase-dependent gene therapy | Q36172573 | ||
| Oncolytic adenovirus armed with IL-24 inhibits the growth of breast cancer in vitro and in vivo | Q36437378 | ||
| c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis. | Q36671497 | ||
| Immunotherapy with dendritic cells and cytokine-induced killer cells for MDA-MB-231 breast cancer stem cells in nude mice | Q37144025 | ||
| Expression of p21ras in fresh primary and metastatic human colorectal tumors | Q37680820 | ||
| The antitumor efficacy of a novel adenovirus-mediated anti-p21Ras single chain fragment variable antibody on human cancers in vitro and in vivo | Q38802236 | ||
| Acquired resistance to cetuximab is associated with the overexpression of Ras family members and the loss of radiosensitization in head and neck cancer cells | Q39119799 | ||
| Adenovirus vector-mediated Gli1 siRNA induces growth inhibition and apoptosis in human pancreatic cancer with Smo-dependent or Smo-independent Hh pathway activation in vitro and in vivo | Q39136637 | ||
| Potent antitumoral effects of targeted promoter-driven oncolytic adenovirus armed with Dm-dNK for breast cancer in vitro and in vivo | Q39273689 | ||
| Hypoxia-inducible factor-1alpha suppresses the expression of macrophage scavenger receptor 1. | Q39819002 | ||
| Adenovirus-mediated thymidine kinase gene therapy and coxsackie adenovirus receptor expression in ovarian cancer cells. | Q39872742 | ||
| A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers | Q39970418 | ||
| Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus | Q40211819 | ||
| Dual promoter-controlled oncolytic adenovirus CG5757 has strong tumor selectivity and significant antitumor efficacy in preclinical models | Q40338941 | ||
| Oncolytic effects of adenovirus mutant capable of replicating in hypoxic and normoxic regions of solid tumor | Q40499227 | ||
| Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo. | Q40539259 | ||
| Direct activation of TERT transcription by c-MYC. | Q40973563 | ||
| Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. | Q41444236 | ||
| A method for detecting intracellular perforin in mouse lymphocytes | Q41687337 | ||
| Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter | Q43192166 | ||
| Cancer therapy with a replicating oncolytic adenovirus targeting the hypoxic microenvironment of tumors | Q45205107 | ||
| P433 | issue | 1 | |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | 40-48 | |
| P577 | publication date | 2016-11-11 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | The antitumor efficacy of anti-p21Ras scFv mediated by the dual-promoter-regulated recombinant adenovirus KGHV300. | |
| P478 | volume | 24 |
Search more.